The groundbreaking rise of Viagra has consistently remained a example of pharmaceutical success, however its position within the broader market now triggers questions about long-term gains. Alternative versions are undercutting market share, prompting anxieties that betting on companies significantly dependent to Viagra's once-dominant position cou